Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05116475
Title Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases (ALADDIN)
Acronym ALADDIN
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Association Pour La Recherche des Therapeutiques Innovantes en Cancerologie
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.